Takeda Pharmaceutical (TAK) Raw Materials (2019)

Takeda Pharmaceutical (TAK) recorded quarterly Raw Materials of $182.2 million in Q1 2019.

Takeda Pharmaceutical (TAK) Raw Materials (2019) Analysis & Trends

Takeda Pharmaceutical's Raw Materials history runs 1 years deep, the most recent figure standing at $182.2 million for Q1 2019.

In Q1 2019, Raw Materials changed N/A year-over-year to $182.2 million; the TTM figure through Mar 2019 stood at $182.2 million (changed N/A YoY), while the FY2019 annual figure was $182.2 million, changed N/A from the prior year.
Raw Materials was $182.2 million for Q1 2019 at Takeda Pharmaceutical.
In the past five years, Raw Materials ranged from a high of $182.2 million in Q1 2019 to a low of $182.2 million in Q1 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Takeda Pharmaceutical	169,609.19	-6.60 Bn	4.39 Bn

Historic Data

Download Data

Date	Value
Mar 31, 2019	182.17 Mn